当前位置：首页 > 报告详情

D2S20-Stewart-v1.2-FINAL.pdf

上传人：好*** 编号：1225277 2026-04-30 PDF PDF 6页 364.06KB

该报告所属合集： 2026年仿制药论坛（Generic Drugs Forum 2026）嘉宾演讲PPT合集

打包下载报告合集

文档加载中……请稍候！
如果长时间未打开，您也可以点击刷新试试。

下载报告到电脑，查找使用更方便

VIP专享文档

书签

已收藏

版权投诉

立即下载

word格式文档无特别注明外均可编辑修改，预览文件经过压缩，下载原文更清晰！

三个皮匠报告文库所有资源均是客户上传分享，仅供网友学习交流，未经上传用户书面授权，请勿作商用。

《D2S20-Stewart-v1.2-FINAL.pdf》由会员分享，可在线阅读，更多相关《D2S20-Stewart-v1.2-FINAL.pdf（6页珍藏版）》请在三个皮匠报告上搜索。

1、Closing RemarksCAPT Kendra StewartDirector,Office of Regulatory OperationsOffice of Generic DrugsCDER|U.S.FDAGeneric Drugs Forum April 23,2026fda.gov/cdersbia2Key TakeawaysAt GDF 2026 we hope you were able to:Build a working knowledge of regulatory practices Learn about our joint commitment to prote

2、cting public health Understand the strategic priorities guiding OGDs workfda.gov/cdersbia3Resource for IndustryOur transparency and published resources assist applicants in their pursuit of approval,which improves patient access to generic medicines.WE ARE THE GENERICDRUG PROGRAMfda.gov/cdersbia5Closing ThoughtsCollaborative Efforts Between FDA and IndustryWell-prepared Generic Drug ApplicationsExpanded Access to Generic Medicines